The Medical Letter, Issue 1144
- Indications for an Implantable Cardioverter Defibrillator p. 99-100
- Hemolysis From Ceftriaxone p. 100-101
- Ibritumomab Tiuxetan (Zevalin) for Non-Hodgkin's Lymphoma p. 101-102
Cannot Access - We are sorry, but you cannot access the requested issue.
If you have already purchased this issue, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this issue, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the issue:
Title: The Medical Letter, Issue 1144
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1144
Date: November 1, 2002
Volume: 44
Pages: 99-102
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1144
Date: November 1, 2002
Volume: 44
Pages: 99-102
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add the postal, hardcopy version of this issue to your cart. (The electronic version of this issue will also be available.)